Quintara Biosciences Completes Acquisition of Laragen Sanger Sequencing Business, Strengthening Service Continuity and Strategic Expansion in Los Angeles

SAN FRANCISCO, Oct. 15, 2025 /PRNewswire/ -- Quintara Biosciences today announced that it has completed the acquisition of Laragen Sanger Sequencing, formerly operated by Transnetyx, effective September 15, 2025. The acquisition ensures uninterrupted service for existing customers while...